越南成人乙型肝炎疫苗接种存在显著缺口:2030年消除乙型肝炎的重要目标
在越南胡志明市2019至2020年开展多阶段整群血清学调查,概率比例规模抽样邀请20000名18岁及以上成人检测HBsAg、anti-HBs和anti-HBc。疫苗诱导免疫(单纯anti-HBs阳性)患病率18.5%(95%CI 17.3-20.0%),易感(HBV naive)患病率37.7%(95%CI 35.6-39.8%)。作者认为成人乙肝疫苗接种需求显著未满足,建议除现有婴儿和风险导向策略外,对更广泛人群推荐接种乙肝疫苗。
要点
- 胡志明市成人疫苗诱导免疫患病率18.5%(95%CI 17.3-20.0%),易感患病率37.7%(95%CI 35.6-39.8%)。
- 非感染人群中30至50岁年龄组疫苗诱导免疫患病率最低。
- 疫苗诱导免疫和易感与危险行为及病史无显著关联。
核心结论
- 胡志明市一般成人群体乙肝疫苗接种需求显著未满足,疫苗诱导免疫缺失在年龄组、地理区域和社会经济状况间分布不均,揭示深刻社会差异。
- 作者认为为实现乙肝消除目标,除现有婴儿和风险导向策略外,应对更广泛人群推荐乙肝疫苗接种。
研究设计与样本
- 2019至2020年在越南胡志明市开展多阶段整群血清学调查,采用概率比例规模抽样,代表性邀请20000名18岁及以上成人进行乙肝筛查(HBsAg、anti-HBs、anti-HBc)。
- 血清学结果定义两个因变量:疫苗诱导免疫(即单纯anti-HBs阳性)和易感(即HBV naive);使用加权Poisson回归评估因变量与调查人口学、社会经济状况、危险行为和病史的关联。
主要发现
- 疫苗诱导免疫患病率为18.5%(95%CI 17.3-20.0%),易感患病率为37.7%(95%CI 35.6-39.8%)。
- 一般人群分析显示疫苗诱导免疫患病率从较年轻年龄组到较年长年龄组呈下降趋势。
- 非感染人群(HBsAg和anti-HBc均阴性)敏感性分析显示,较年轻年龄组尤其是30至50岁年龄组疫苗诱导免疫患病率最低。
- 不同民族、居住区域、教育水平、房屋所有权和医疗保险状况之间存在社会不平等。
- 疫苗诱导免疫或易感与危险行为和病史之间无显著关联。
关键数值与推荐
- 疫苗诱导免疫定义为单纯anti-HBs阳性,患病率18.5%(95%CI 17.3-20.0%)。
- 易感定义为HBV naive,患病率37.7%(95%CI 35.6-39.8%)。
临床怎么用
- 作者认为为实现乙肝消除目标,除现有婴儿和风险导向策略外,应对更广泛人群推荐乙肝疫苗接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gaps in adult hepatitis B vaccination were undefined in Vietnam, a lower-middle-income country. To address these gaps, this study defined hepatitis B vaccine coverage in adults and its associated factors in Ho Chi Minh City (HCMC), Viet Nam. We also proposed interventional strategies, prioritizing gap identification to facilitate hepatitis B elimination by 2030 and beyond. METHOD: During 2019-2020, a multi-stage cluster serosurvey with probability proportional to size was conducted to representatively invite 20,000 adults (18 years or older) throughout HCMC for hepatitis B screening (HBsAg, anti-HBs, and anti-HBc). Serologic results defined two dependent variables: vaccine-induced immunity (i.e., isolated anti-HBs) and susceptibility (i.e., HBV naive). Associations of dependent variables with surveyed demographics, socioeconomic statuses, behaviors, and medical history at risk for hepatitis B were evaluated using weighted Poisson regression. RESULTS: The prevalence was 18.5% (95%CI, 17.3-20.0%) for vaccine-induced immunity and 37.7% (35.6-39.8%) for susceptibility. Even though analyses in the general population revealed a falling trend in vaccine-induced immunity prevalence from younger to older age groups, sensitivity analyses in the non-infected population (i.e., those who were both negative for HBsAg and anti-HBc) showed that younger age groups, especially those aged 30 to 50 years, had the lowest prevalence. Social inequalities existed in different ethnicities, residence areas, education levels, house ownership, and health insurance statuses. There was no significant association between vaccine-induced immunity or susceptibility and risky behaviors and medical histories. CONCLUSION: This study depicts a significant unmet need for hepatitis B vaccination in the general adult population in HCMC, Viet Nam. Indeed, the lack of vaccination was unevenly distributed regarding age groups, geographical areas, and socioeconomic statuses, which reveals profound social disparities. Therefore, to achieve hepatitis B elimination goals, besides the current recommendations for infants and risk-based strategies, hepatitis B vaccination should be recommended for the broader population.
引用
- Kim TV, Pham TND, Le DH, et al. Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030. Vaccine. 2023. PMID: 36588006. doi:10.1016/j.vaccine.2022.12.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。